Rang	Name	Position
1	Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.	Founder, Chairman & CEO
2	Mr. Michael I. Benkowitz	President & COO
3	Mr. James C. Edgemond	CFO & Treasurer
4	Mr. Paul A. Mahon J.D.	Executive VP, General Counsel & Corporate Secretary
5	Harrison Silvers	Manager of Investor Relations
6	Ms. Holly Hobson	Associate Vice President of Human Resources
7	Mr. Patrick Poisson	Executive Vice President of Strategic Development
8	Dr. Leigh Peterson	Executive Vice President of Product Development & Xenotransplantation
9	Mr. Gil Golden	Senior VP & Chief Medical Officer

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	12,37%	2,64 Mrd. USD
2	venBio Select Advisor LLC	6,03%	1,29 Mrd. USD
3	Vanguard Portfolio Management, LLC	4,59%	0,98 Mrd. USD
4	Vanguard Capital Management, LLC	4,49%	0,96 Mrd. USD
5	State Street Corp	4,23%	0,90 Mrd. USD
6	Renaissance Technologies Corp	4,09%	0,87 Mrd. USD
7	Wellington Management Company LLP	3,16%	0,67 Mrd. USD
8	Geode Capital Management, LLC	2,83%	0,60 Mrd. USD
9	HHG PLC	1,99%	0,42 Mrd. USD
10	AQR Capital Management LLC	1,89%	0,40 Mrd. USD
11	NORGES BANK	1,59%	0,34 Mrd. USD
12	Genworth Financial Wealth Mgmt Inc	1,41%	0,30 Mrd. USD
13	Amvescap Plc.	1,39%	0,30 Mrd. USD
14	FMR Inc	1,21%	0,26 Mrd. USD
15	Dimensional Fund Advisors, Inc.	1,21%	0,26 Mrd. USD
16	Baillie Gifford & Co Limited.	1,07%	0,23 Mrd. USD
17	Deerfield Management Co	1,05%	0,22 Mrd. USD
18	Northern Trust Corp	1,00%	0,21 Mrd. USD
19	Morgan Stanley - Brokerage Accounts	0,94%	0,20 Mrd. USD
20	Millennium Management LLC	0,94%	0,20 Mrd. USD